Back to Search Start Over

Activated integrins identify functional antigen-specific CD8 + T cells within minutes after antigen stimulation.

Authors :
Dimitrov S
Gouttefangeas C
Besedovsky L
Jensen ATR
Chandran PA
Rusch E
Businger R
Schindler M
Lange T
Born J
Rammensee HG
Source :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Jun 12; Vol. 115 (24), pp. E5536-E5545. Date of Electronic Publication: 2018 May 29.
Publication Year :
2018

Abstract

Immediate β <subscript>2</subscript> -integrin activation upon T cell receptor stimulation is critical for effective interaction between T cells and their targets and may therefore be used for the rapid identification and isolation of functional T cells. We present a simple and sensitive flow cytometry-based assay to assess antigen-specific T cells using fluorescent intercellular adhesion molecule (ICAM)-1 multimers that specifically bind to activated β <subscript>2</subscript> -integrins. The method is compatible with surface and intracellular staining; it is applicable for monitoring of a broad range of virus-, tumor-, and vaccine-specific CD8 <superscript>+</superscript> T cells, and for isolating viable antigen-reacting cells. ICAM-1 binding correlates with peptide-MHC multimer binding but, notably, it identifies the fraction of antigen-specific CD8 <superscript>+</superscript> T cells with immediate and high functional capability (i.e., expressing high levels of cytotoxic markers and cytokines). Compared with the currently available methods, staining of activated β <subscript>2</subscript> -integrins presents the unique advantage of requiring activation times of only several minutes, therefore delivering functional information nearly reflecting the in vivo situation. Hence, the ICAM-1 assay is most suitable for rapid and precise monitoring of functional antigen-specific T cell responses, including for patient samples in a variety of clinical settings, as well as for the isolation of functional T cells for adoptive cell-transfer immunotherapies.<br />Competing Interests: The authors declare no conflict of interest.<br /> (Copyright © 2018 the Author(s). Published by PNAS.)

Details

Language :
English
ISSN :
1091-6490
Volume :
115
Issue :
24
Database :
MEDLINE
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
29844168
Full Text :
https://doi.org/10.1073/pnas.1720714115